| Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons S Moonen, MJ Koper, E Van Schoor, JM Schaeverbeke, R Vandenberghe, ... Acta Neuropathologica 145 (2), 175-195, 2023 | 100 | 2023 |
| MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study M Ten Kate, A Redolfi, E Peira, I Bos, SJ Vos, R Vandenberghe, S Gabel, ... Alzheimer's research & therapy 10, 1-12, 2018 | 80 | 2018 |
| Comparison of ELISA-and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis S De Meyer, JM Schaeverbeke, IMW Verberk, B Gille, M De Schaepdryver, ... Alzheimer's research & therapy 12, 1-16, 2020 | 76 | 2020 |
| Core auditory processing deficits in primary progressive aphasia M Grube, R Bruffaerts, J Schaeverbeke, V Neyens, AS De Weer, ... Brain 139 (6), 1817-1829, 2016 | 75 | 2016 |
| Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease FSH Al-Shaikh, R Duara, JE Crook, ER Lesser, J Schaeverbeke, ... JAMA neurology 77 (2), 225-233, 2020 | 67 | 2020 |
| Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease K Adamczuk, J Schaeverbeke, HMJ Vanderstichele, J Lilja, N Nelissen, ... Alzheimer's research & therapy 7, 1-11, 2015 | 55 | 2015 |
| Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset S Hong, D Prokopenko, V Dobricic, F Kilpert, I Bos, SJB Vos, BM Tijms, ... Translational psychiatry 10 (1), 403, 2020 | 54 | 2020 |
| Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease K Delmotte, J Schaeverbeke, K Poesen, R Vandenberghe Alzheimer's research & therapy 13, 1-13, 2021 | 48 | 2021 |
| Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context G Vanderschaeghe, J Schaeverbeke, R Bruffaerts, R Vandenberghe, ... Alzheimer's research & therapy 9, 1-16, 2017 | 48 | 2017 |
| Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B K Adamczuk, J Schaeverbeke, N Nelissen, V Neyens, M Vandenbulcke, ... European journal of nuclear medicine and molecular imaging 43, 142-151, 2016 | 44 | 2016 |
| Serum neurofilament heavy chains as early marker of motor neuron degeneration M De Schaepdryver, J Goossens, S De Meyer, A Jeromin, P Masrori, ... Annals of clinical and translational neurology 6 (10), 1971-1979, 2019 | 42 | 2019 |
| 3D shape perception in posterior cortical atrophy: a visual neuroscience perspective CR Gillebert, J Schaeverbeke, C Bastin, V Neyens, R Bruffaerts, ... Journal of Neuroscience 35 (37), 12673-12692, 2015 | 35 | 2015 |
| Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults JM Schaeverbeke, S Gabel, K Meersmans, ES Luckett, S De Meyer, ... Alzheimer's Research & Therapy 13, 1-16, 2021 | 33 | 2021 |
| Multivariate analysis reveals anatomical correlates of naming errors in primary progressive aphasia R Bruffaerts, J Schaeverbeke, AS De Weer, N Nelissen, E Dries, ... Neurobiology of aging 88, 71-82, 2020 | 29 | 2020 |
| Amnestic MCI patients’ perspectives toward disclosure of amyloid PET results in a research context G Vanderschaeghe, J Schaeverbeke, R Vandenberghe, K Dierickx Neuroethics 10, 281-297, 2017 | 29 | 2017 |
| Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia J Schaeverbeke, S Gabel, K Meersmans, R Bruffaerts, AG Liuzzi, ... Alzheimer's research & therapy 10, 1-20, 2018 | 25 | 2018 |
| Reproducibility of graph measures at the subject level using resting‐state fMRI Q Ran, T Jamoulle, J Schaeverbeke, K Meersmans, R Vandenberghe, ... Brain and behavior 10 (8), 2336-2351, 2020 | 24 | 2020 |
| Cholinergic depletion and basal forebrain volume in primary progressive aphasia J Schaeverbeke, C Evenepoel, R Bruffaerts, K Van Laere, G Bormans, ... NeuroImage: Clinical 13, 271-279, 2017 | 24 | 2017 |
| LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease MJ Koper, SO Tomé, K Gawor, A Belet, E Van Schoor, J Schaeverbeke, ... Acta Neuropathologica Communications 10 (1), 128, 2022 | 19 | 2022 |
| From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting G Vanderschaeghe, J Schaeverbeke, R Bruffaerts, R Vandenberghe, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018 | 19 | 2018 |
Rik VandenbergheUniversity of LeuvenVerified email at uz.kuleuven.ac.be
